CLINICAL_TRIALS
trial_result
· 2021-04-14
Clinical Trial Update: Xenform Postmarket Surveillance Study [NA]
Summary
Postmarket surveillance study update for Xenform; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Pelvic Organ Prolapse | NA | Status: COMPLETED | Results posted: 2021-04-14